Please note that the copy function is not enabled for this field.
If you wish to
modify
existing outcomes, please copy and paste the current outcome text into the Update field.
LOGIN
CREATE ACCOUNT
LOGIN
CREATE ACCOUNT
MY TRIALS
REGISTER TRIAL
FAQs
HINTS AND TIPS
DEFINITIONS
Trial Review
The ANZCTR website will be unavailable from 1pm until 3pm (AEDT) on Wednesday the 30th of October for website maintenance. Please be sure to log out of the system in order to avoid any loss of data.
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this
information for consumers
Download to PDF
Trial details imported from ClinicalTrials.gov
For full trial details, please see the original record at
https://clinicaltrials.gov/study/NCT02641392
Registration number
NCT02641392
Ethics application status
Date submitted
23/12/2015
Date registered
29/12/2015
Date last updated
29/01/2019
Titles & IDs
Public title
A Long-term Active Treatment Study of Mongersen (GED-0301) in Subjects With Crohn's Disease
Query!
Scientific title
A Phase 3, Long-term Active Treatment Extension Study of Mongersen (GED-0301) in Subjects With Crohn's Disease
Query!
Secondary ID [1]
0
0
GED-0301-CD-004
Query!
Universal Trial Number (UTN)
Query!
Trial acronym
Query!
Linked study record
Query!
Health condition
Health condition(s) or problem(s) studied:
Crohn's Disease
0
0
Query!
Condition category
Condition code
Oral and Gastrointestinal
0
0
0
0
Query!
Inflammatory bowel disease
Query!
Inflammatory and Immune System
0
0
0
0
Query!
Other inflammatory or immune system disorders
Query!
Oral and Gastrointestinal
0
0
0
0
Query!
Crohn's disease
Query!
Intervention/exposure
Study type
Interventional
Query!
Description of intervention(s) / exposure
Treatment: Drugs - GED-0301
Other interventions - Placebo
Experimental: GED-0301 (160 mg) followed by Placebo intermittent 160 mg - GED-0301 160 mg once daily (QD) for 12 weeks, followed by alternating Placebo (PBO) QD for 4 weeks with GED 0301 160 mg QD for 4 weeks, up to 208 weeks, if the subject previously received Placebo in the prior GED-0301 Study
Experimental: Intermittent GED-0301 160 mg and placebo - Alternating GED-0301 160 mg once daily (QD) for 4 weeks with placebo (PBO) QD for 4 weeks, up to 208 weeks, depending on previous response in the prior GED-0301 study
Experimental: Intermittent placebo and GED-0301 40 mg - Alternating PBO once daily (QD) for 4 weeks with GED-0301 40 mg QD for 4 weeks with, up to 208 weeks, depending on previous response in the prior GED-0301 study
Experimental: Continuous GED-0301 40 mg - GED-0301 40 mg once daily (QD) for up to 208 weeks
Experimental: Intermittent placebo and GED-0301 160 mg - Alternating PBO QD for 4 weeks with GED-0301 160 mg QD for 4 weeks, through Week 208
Treatment: Drugs: GED-0301
Mongersen
Other interventions: Placebo
Placebo
Query!
Intervention code [1]
0
0
Treatment: Drugs
Query!
Intervention code [2]
0
0
Other interventions
Query!
Comparator / control treatment
Query!
Control group
Query!
Outcomes
Primary outcome [1]
0
0
Number of Participants With Treatment Emergent Adverse Events From Week 0 to Week 208
Query!
Assessment method [1]
0
0
A TEAE was defined as any adverse event (AE) occurring or worsening on or after the first treatment of GED-0301 and up to 28 days after the last GED- 0301 dose or the last follow-up date, whichever occurred earlier. A serious AE = any AE which results in death; is life-threatening; requires inpatient hospitalization or prolongation of existing hospitalization; results in persistent or significant disability/incapacity; is a congenital anomaly/birth defect; constitutes an important medical event. The severity of AEs was assessed by the investigator and based on the following scale; Mild = asymptomatic or mild symptoms; clinical or diagnostic observations only; Moderate = Symptoms cause moderate discomfort; Severe (could be non-serious or serious) = symptoms causing severe discomfort/pain.
Query!
Timepoint [1]
0
0
From the first day of GED-0301 until 28 days after the last dose of IP; maximum treatment duration was 16.1 weeks in the GED-0301 40 mg Alt dose; 16.3 weeks in the GED 40 mg continuous dose and 56.1 weeks in the GED-0301 160 mg Alt dose
Query!
Eligibility
Key inclusion criteria
Inclusion Criteria for Adult Subjects:
Subjects must satisfy the following criteria to be screened and enrolled in the study:
* Male or female = 18 years of age.
* Subject must have participated in the GED-0301-CD-002 or GED 0301 CD 003 study.
* Subject must use protocol approved contraception.
Inclusion Criteria for Adolescent Subjects:
Adolescent subjects must satisfy the following criteria to be screened and enrolled in the study
* Male or female 12 to 17 years of age.
* Subject must have participated in the GED 0301 CD 003 study.
* Subject is able to swallow the IP tablets.
* Subject must use protocol approved contraception.
Query!
Minimum age
12
Years
Query!
Query!
Maximum age
No limit
Query!
Query!
Sex
Both males and females
Query!
Can healthy volunteers participate?
No
Query!
Key exclusion criteria
Exclusion Criteria for Adult and Adolescent Subjects:
The presence of any of the following will exclude a subject from screening and enrollment:
* Subject had experienced a serious adverse event (SAE) related to the investigational product while participating in the previous Phase 3 GED-0301 study.
* Subject has initiated biologic agents, such as TNF-a blockers or integrin antagonists.
* Subject is pregnant or breastfeeding.
* Subject has developed a known hypersensitivity to oligonucleotides, GED 0301 or any ingredient in the investigational product.
Query!
Study design
Purpose of the study
Treatment
Query!
Allocation to intervention
Randomised controlled trial
Query!
Procedure for enrolling a subject and allocating the treatment (allocation concealment procedures)
Query!
Methods used to generate the sequence in which subjects will be randomised (sequence generation)
Query!
Masking / blinding
Blinded (masking used)
Query!
Who is / are masked / blinded?
The people receiving the treatment/s
The people administering the treatment/s
The people assessing the outcomes
The people analysing the results/data
Query!
Query!
Query!
Query!
Intervention assignment
Parallel
Query!
Other design features
Query!
Phase
Phase 3
Query!
Type of endpoint/s
Query!
Statistical methods / analysis
Query!
Recruitment
Recruitment status
Stopped early
Query!
Data analysis
Query!
Reason for early stopping/withdrawal
Query!
Other reasons
Query!
Date of first participant enrolment
Anticipated
Query!
Actual
25/07/2016
Query!
Date of last participant enrolment
Anticipated
Query!
Actual
Query!
Date of last data collection
Anticipated
Query!
Actual
4/01/2018
Query!
Sample size
Target
Query!
Accrual to date
Query!
Final
310
Query!
Recruitment in Australia
Recruitment state(s)
NSW,QLD,SA,VIC
Query!
Recruitment hospital [1]
0
0
Concord Repatriation General Hospital - Concord
Query!
Recruitment hospital [2]
0
0
Centre For Digestive Diseases - Five Dock
Query!
Recruitment hospital [3]
0
0
Liverpool Hospital - Liverpool
Query!
Recruitment hospital [4]
0
0
Mater Adult Hospital - South Brisbane
Query!
Recruitment hospital [5]
0
0
Royal Adelaide Hospital - Adelaide
Query!
Recruitment hospital [6]
0
0
Box Hill Hospital - Box Hill
Query!
Recruitment hospital [7]
0
0
The Alfred Hospital - Melbourne
Query!
Recruitment hospital [8]
0
0
Monash Medical Centre Clayton - Bentleigh East
Query!
Recruitment postcode(s) [1]
0
0
2139 - Concord
Query!
Recruitment postcode(s) [2]
0
0
2046 - Five Dock
Query!
Recruitment postcode(s) [3]
0
0
2170 - Liverpool
Query!
Recruitment postcode(s) [4]
0
0
4101 - South Brisbane
Query!
Recruitment postcode(s) [5]
0
0
5000 - Adelaide
Query!
Recruitment postcode(s) [6]
0
0
3128 - Box Hill
Query!
Recruitment postcode(s) [7]
0
0
3004 - Melbourne
Query!
Recruitment postcode(s) [8]
0
0
3165 - Bentleigh East
Query!
Recruitment outside Australia
Country [1]
0
0
United States of America
Query!
State/province [1]
0
0
California
Query!
Country [2]
0
0
United States of America
Query!
State/province [2]
0
0
Georgia
Query!
Country [3]
0
0
United States of America
Query!
State/province [3]
0
0
Indiana
Query!
Country [4]
0
0
United States of America
Query!
State/province [4]
0
0
Kansas
Query!
Country [5]
0
0
United States of America
Query!
State/province [5]
0
0
Louisiana
Query!
Country [6]
0
0
United States of America
Query!
State/province [6]
0
0
Maryland
Query!
Country [7]
0
0
United States of America
Query!
State/province [7]
0
0
Michigan
Query!
Country [8]
0
0
United States of America
Query!
State/province [8]
0
0
Missouri
Query!
Country [9]
0
0
United States of America
Query!
State/province [9]
0
0
New York
Query!
Country [10]
0
0
United States of America
Query!
State/province [10]
0
0
North Carolina
Query!
Country [11]
0
0
United States of America
Query!
State/province [11]
0
0
Tennessee
Query!
Country [12]
0
0
United States of America
Query!
State/province [12]
0
0
Texas
Query!
Country [13]
0
0
United States of America
Query!
State/province [13]
0
0
Washington
Query!
Country [14]
0
0
Austria
Query!
State/province [14]
0
0
Graz
Query!
Country [15]
0
0
Austria
Query!
State/province [15]
0
0
Innsbruck
Query!
Country [16]
0
0
Austria
Query!
State/province [16]
0
0
Linz
Query!
Country [17]
0
0
Austria
Query!
State/province [17]
0
0
Salzburg
Query!
Country [18]
0
0
Austria
Query!
State/province [18]
0
0
St Veit An Der Glan
Query!
Country [19]
0
0
Austria
Query!
State/province [19]
0
0
Wein
Query!
Country [20]
0
0
Belgium
Query!
State/province [20]
0
0
Brussels
Query!
Country [21]
0
0
Belgium
Query!
State/province [21]
0
0
Leuven
Query!
Country [22]
0
0
Belgium
Query!
State/province [22]
0
0
Liege
Query!
Country [23]
0
0
Bulgaria
Query!
State/province [23]
0
0
Plovdiv
Query!
Country [24]
0
0
Bulgaria
Query!
State/province [24]
0
0
Ruse
Query!
Country [25]
0
0
Bulgaria
Query!
State/province [25]
0
0
Sofia
Query!
Country [26]
0
0
Canada
Query!
State/province [26]
0
0
Alberta
Query!
Country [27]
0
0
Canada
Query!
State/province [27]
0
0
British Columbia
Query!
Country [28]
0
0
Canada
Query!
State/province [28]
0
0
Manitoba
Query!
Country [29]
0
0
Canada
Query!
State/province [29]
0
0
Ontario
Query!
Country [30]
0
0
Canada
Query!
State/province [30]
0
0
Quebec
Query!
Country [31]
0
0
Croatia
Query!
State/province [31]
0
0
Osijek
Query!
Country [32]
0
0
Czechia
Query!
State/province [32]
0
0
Brno
Query!
Country [33]
0
0
Czechia
Query!
State/province [33]
0
0
Hradec Kralove
Query!
Country [34]
0
0
Czechia
Query!
State/province [34]
0
0
Olomouc
Query!
Country [35]
0
0
Czechia
Query!
State/province [35]
0
0
Praha 3
Query!
Country [36]
0
0
Denmark
Query!
State/province [36]
0
0
Aahus C
Query!
Country [37]
0
0
Denmark
Query!
State/province [37]
0
0
Alborg
Query!
Country [38]
0
0
Denmark
Query!
State/province [38]
0
0
Frederikssund
Query!
Country [39]
0
0
Denmark
Query!
State/province [39]
0
0
Herlev
Query!
Country [40]
0
0
Denmark
Query!
State/province [40]
0
0
Koge
Query!
Country [41]
0
0
Denmark
Query!
State/province [41]
0
0
Silkeborg
Query!
Country [42]
0
0
France
Query!
State/province [42]
0
0
Amiens Cedex
Query!
Country [43]
0
0
France
Query!
State/province [43]
0
0
Besancon Cedex
Query!
Country [44]
0
0
France
Query!
State/province [44]
0
0
Chambray les Tours
Query!
Country [45]
0
0
France
Query!
State/province [45]
0
0
Clermont-Ferrand
Query!
Country [46]
0
0
France
Query!
State/province [46]
0
0
Clichy cedex
Query!
Country [47]
0
0
France
Query!
State/province [47]
0
0
Nantes Cedex 1
Query!
Country [48]
0
0
France
Query!
State/province [48]
0
0
Nice Cedex 3
Query!
Country [49]
0
0
France
Query!
State/province [49]
0
0
Pessac
Query!
Country [50]
0
0
France
Query!
State/province [50]
0
0
Pierre Benite cedex
Query!
Country [51]
0
0
France
Query!
State/province [51]
0
0
Reims
Query!
Country [52]
0
0
France
Query!
State/province [52]
0
0
Rennes cedex 09
Query!
Country [53]
0
0
France
Query!
State/province [53]
0
0
Saint Etienne
Query!
Country [54]
0
0
France
Query!
State/province [54]
0
0
Strasbourg Cedex
Query!
Country [55]
0
0
France
Query!
State/province [55]
0
0
Toulouse Cedex 09
Query!
Country [56]
0
0
France
Query!
State/province [56]
0
0
Vandoeuvre les Nancy
Query!
Country [57]
0
0
Germany
Query!
State/province [57]
0
0
Berlin
Query!
Country [58]
0
0
Germany
Query!
State/province [58]
0
0
Bochum
Query!
Country [59]
0
0
Germany
Query!
State/province [59]
0
0
Dresden
Query!
Country [60]
0
0
Germany
Query!
State/province [60]
0
0
Erlangen
Query!
Country [61]
0
0
Germany
Query!
State/province [61]
0
0
Essen
Query!
Country [62]
0
0
Germany
Query!
State/province [62]
0
0
Frankfurt
Query!
Country [63]
0
0
Germany
Query!
State/province [63]
0
0
Halle
Query!
Country [64]
0
0
Germany
Query!
State/province [64]
0
0
Hamburg
Query!
Country [65]
0
0
Germany
Query!
State/province [65]
0
0
Hannover
Query!
Country [66]
0
0
Germany
Query!
State/province [66]
0
0
Heidelberg
Query!
Country [67]
0
0
Germany
Query!
State/province [67]
0
0
Jena
Query!
Country [68]
0
0
Germany
Query!
State/province [68]
0
0
Kiel
Query!
Country [69]
0
0
Germany
Query!
State/province [69]
0
0
Leipzig
Query!
Country [70]
0
0
Germany
Query!
State/province [70]
0
0
Lueneburg
Query!
Country [71]
0
0
Germany
Query!
State/province [71]
0
0
Mannheim
Query!
Country [72]
0
0
Germany
Query!
State/province [72]
0
0
Muenster
Query!
Country [73]
0
0
Germany
Query!
State/province [73]
0
0
München
Query!
Country [74]
0
0
Germany
Query!
State/province [74]
0
0
Niedersachsen
Query!
Country [75]
0
0
Germany
Query!
State/province [75]
0
0
Regensburg
Query!
Country [76]
0
0
Germany
Query!
State/province [76]
0
0
Ulm
Query!
Country [77]
0
0
Greece
Query!
State/province [77]
0
0
Alexandroupolis
Query!
Country [78]
0
0
Greece
Query!
State/province [78]
0
0
Athens
Query!
Country [79]
0
0
Greece
Query!
State/province [79]
0
0
Rio Patras
Query!
Country [80]
0
0
Hungary
Query!
State/province [80]
0
0
Balatonfured
Query!
Country [81]
0
0
Hungary
Query!
State/province [81]
0
0
Budapest
Query!
Country [82]
0
0
Hungary
Query!
State/province [82]
0
0
Debrecen
Query!
Country [83]
0
0
Hungary
Query!
State/province [83]
0
0
Dunaujvaros
Query!
Country [84]
0
0
Hungary
Query!
State/province [84]
0
0
Gyor
Query!
Country [85]
0
0
Hungary
Query!
State/province [85]
0
0
Szekszard
Query!
Country [86]
0
0
Israel
Query!
State/province [86]
0
0
Afula
Query!
Country [87]
0
0
Israel
Query!
State/province [87]
0
0
Beer Sheva
Query!
Country [88]
0
0
Israel
Query!
State/province [88]
0
0
Haifa
Query!
Country [89]
0
0
Israel
Query!
State/province [89]
0
0
Jerusalem
Query!
Country [90]
0
0
Israel
Query!
State/province [90]
0
0
Petah Tikva
Query!
Country [91]
0
0
Israel
Query!
State/province [91]
0
0
Ramat Gan
Query!
Country [92]
0
0
Israel
Query!
State/province [92]
0
0
Rechovot
Query!
Country [93]
0
0
Israel
Query!
State/province [93]
0
0
Tel Aviv
Query!
Country [94]
0
0
Israel
Query!
State/province [94]
0
0
Tiberias
Query!
Country [95]
0
0
Israel
Query!
State/province [95]
0
0
Zerifin
Query!
Country [96]
0
0
Italy
Query!
State/province [96]
0
0
Bologna
Query!
Country [97]
0
0
Italy
Query!
State/province [97]
0
0
Messina
Query!
Country [98]
0
0
Italy
Query!
State/province [98]
0
0
Milano
Query!
Country [99]
0
0
Italy
Query!
State/province [99]
0
0
Palermo
Query!
Country [100]
0
0
Italy
Query!
State/province [100]
0
0
Pavia
Query!
Country [101]
0
0
Italy
Query!
State/province [101]
0
0
Roma
Query!
Country [102]
0
0
Italy
Query!
State/province [102]
0
0
Rome
Query!
Country [103]
0
0
Italy
Query!
State/province [103]
0
0
Rozzano (MI)
Query!
Country [104]
0
0
Italy
Query!
State/province [104]
0
0
San Donato Milanese
Query!
Country [105]
0
0
Italy
Query!
State/province [105]
0
0
San Giovanni Rotondo FG
Query!
Country [106]
0
0
Korea, Republic of
Query!
State/province [106]
0
0
Busan
Query!
Country [107]
0
0
Korea, Republic of
Query!
State/province [107]
0
0
Daegu
Query!
Country [108]
0
0
Korea, Republic of
Query!
State/province [108]
0
0
Guri-si
Query!
Country [109]
0
0
Korea, Republic of
Query!
State/province [109]
0
0
Seongnam-si,
Query!
Country [110]
0
0
Korea, Republic of
Query!
State/province [110]
0
0
Seongnam-si
Query!
Country [111]
0
0
Korea, Republic of
Query!
State/province [111]
0
0
Seoul
Query!
Country [112]
0
0
Latvia
Query!
State/province [112]
0
0
Riga
Query!
Country [113]
0
0
Netherlands
Query!
State/province [113]
0
0
Amsterdam
Query!
Country [114]
0
0
Netherlands
Query!
State/province [114]
0
0
Breda
Query!
Country [115]
0
0
Netherlands
Query!
State/province [115]
0
0
Nijmegen
Query!
Country [116]
0
0
Netherlands
Query!
State/province [116]
0
0
Sittard-Geleen
Query!
Country [117]
0
0
Netherlands
Query!
State/province [117]
0
0
Tilburg
Query!
Country [118]
0
0
Norway
Query!
State/province [118]
0
0
Lørenskog
Query!
Country [119]
0
0
Norway
Query!
State/province [119]
0
0
Oslo
Query!
Country [120]
0
0
Poland
Query!
State/province [120]
0
0
Kielce
Query!
Country [121]
0
0
Poland
Query!
State/province [121]
0
0
Knurow
Query!
Country [122]
0
0
Poland
Query!
State/province [122]
0
0
Lodz
Query!
Country [123]
0
0
Poland
Query!
State/province [123]
0
0
Rzeszow
Query!
Country [124]
0
0
Poland
Query!
State/province [124]
0
0
Sopot
Query!
Country [125]
0
0
Portugal
Query!
State/province [125]
0
0
Braga
Query!
Country [126]
0
0
Portugal
Query!
State/province [126]
0
0
Guimaraes
Query!
Country [127]
0
0
Romania
Query!
State/province [127]
0
0
Bucuresti
Query!
Country [128]
0
0
Romania
Query!
State/province [128]
0
0
Oradea
Query!
Country [129]
0
0
Romania
Query!
State/province [129]
0
0
Timisoara
Query!
Country [130]
0
0
Russian Federation
Query!
State/province [130]
0
0
Krasnoyarsk
Query!
Country [131]
0
0
Russian Federation
Query!
State/province [131]
0
0
Nizhny Novgorod
Query!
Country [132]
0
0
Russian Federation
Query!
State/province [132]
0
0
Novosibirsk
Query!
Country [133]
0
0
Russian Federation
Query!
State/province [133]
0
0
Pushkin
Query!
Country [134]
0
0
Russian Federation
Query!
State/province [134]
0
0
Rostov-on-Don
Query!
Country [135]
0
0
Russian Federation
Query!
State/province [135]
0
0
Saint-Petersburg
Query!
Country [136]
0
0
Russian Federation
Query!
State/province [136]
0
0
Samara
Query!
Country [137]
0
0
Serbia
Query!
State/province [137]
0
0
Belgrade
Query!
Country [138]
0
0
Slovakia
Query!
State/province [138]
0
0
Banska Bystrica
Query!
Country [139]
0
0
Slovakia
Query!
State/province [139]
0
0
Bardejov
Query!
Country [140]
0
0
Slovakia
Query!
State/province [140]
0
0
Malacky
Query!
Country [141]
0
0
Slovakia
Query!
State/province [141]
0
0
Nitra
Query!
Country [142]
0
0
Slovakia
Query!
State/province [142]
0
0
Presov
Query!
Country [143]
0
0
Spain
Query!
State/province [143]
0
0
Barcelona
Query!
Country [144]
0
0
Spain
Query!
State/province [144]
0
0
Majadahonda
Query!
Country [145]
0
0
Spain
Query!
State/province [145]
0
0
Sabadell
Query!
Country [146]
0
0
Spain
Query!
State/province [146]
0
0
Zaragoza
Query!
Country [147]
0
0
Sweden
Query!
State/province [147]
0
0
Stockholm
Query!
Country [148]
0
0
Switzerland
Query!
State/province [148]
0
0
Bern
Query!
Country [149]
0
0
Turkey
Query!
State/province [149]
0
0
Ankara
Query!
Country [150]
0
0
Turkey
Query!
State/province [150]
0
0
Istanbul
Query!
Country [151]
0
0
Turkey
Query!
State/province [151]
0
0
Izmir
Query!
Country [152]
0
0
Turkey
Query!
State/province [152]
0
0
Kocaeli
Query!
Country [153]
0
0
Ukraine
Query!
State/province [153]
0
0
Chernivtsi
Query!
Country [154]
0
0
Ukraine
Query!
State/province [154]
0
0
Kharkiv
Query!
Country [155]
0
0
Ukraine
Query!
State/province [155]
0
0
Kirovohrad
Query!
Country [156]
0
0
Ukraine
Query!
State/province [156]
0
0
Kyiv
Query!
Country [157]
0
0
Ukraine
Query!
State/province [157]
0
0
Odessa
Query!
Country [158]
0
0
Ukraine
Query!
State/province [158]
0
0
Ternopil
Query!
Country [159]
0
0
Ukraine
Query!
State/province [159]
0
0
Zaporozhje
Query!
Country [160]
0
0
United Kingdom
Query!
State/province [160]
0
0
Exeter
Query!
Country [161]
0
0
United Kingdom
Query!
State/province [161]
0
0
Glasgow, Scotland
Query!
Country [162]
0
0
United Kingdom
Query!
State/province [162]
0
0
Glasgow
Query!
Country [163]
0
0
United Kingdom
Query!
State/province [163]
0
0
Hull
Query!
Country [164]
0
0
United Kingdom
Query!
State/province [164]
0
0
London
Query!
Country [165]
0
0
United Kingdom
Query!
State/province [165]
0
0
Manchester
Query!
Country [166]
0
0
United Kingdom
Query!
State/province [166]
0
0
Nottingham
Query!
Country [167]
0
0
United Kingdom
Query!
State/province [167]
0
0
Oxford
Query!
Country [168]
0
0
United Kingdom
Query!
State/province [168]
0
0
Shrewsbury
Query!
Funding & Sponsors
Primary sponsor type
Commercial sector/industry
Query!
Name
Celgene
Query!
Address
Query!
Country
Query!
Ethics approval
Ethics application status
Query!
Summary
Brief summary
The purpose of this study is to assess long-term safety data of GED-0301 for a period of up to 208 weeks in adult subjects (i.e., = 18 years of age) who participated in the core Phase 3 GED-0301-CD-002 and GED-0301-CD-003 studies and adolescent subjects (i.e., 12 to 17 years of age) who participated in the core Phase 3 GED-0301-CD-003 study. Although all subjects will receive active treatment, this study is double-blinded for the entire 208 weeks for the purpose of preserving the blind of the subject's treatment allocation in the initial, core Phase 3 GED-0301 study. The GED-0301-CD-003 trial was not initiated; see detailed description.
Query!
Trial website
https://clinicaltrials.gov/study/NCT02641392
Query!
Trial related presentations / publications
Query!
Public notes
Query!
Contacts
Principal investigator
Name
0
0
Guillermo Rossiter, MD
Query!
Address
0
0
Celgene
Query!
Country
0
0
Query!
Phone
0
0
Query!
Fax
0
0
Query!
Email
0
0
Query!
Contact person for public queries
Name
0
0
Query!
Address
0
0
Query!
Country
0
0
Query!
Phone
0
0
Query!
Fax
0
0
Query!
Email
0
0
Query!
Contact person for scientific queries
No information has been provided regarding IPD availability
What supporting documents are/will be available?
No Supporting Document Provided
Type
Other Details
Attachment
Study protocol
https://cdn.clinicaltrials.gov/large-docs/92/NCT02641392/Prot_000.pdf
Statistical analysis plan
https://cdn.clinicaltrials.gov/large-docs/92/NCT02641392/SAP_001.pdf
Results publications and other study-related documents
No documents have been uploaded by study researchers.
Results not provided in
https://clinicaltrials.gov/study/NCT02641392
Download to PDF